Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Medicinal Chemistry
  4. Volume 31, Issue 38
  5. Article
Volume 31, Issue 38
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Introduction

During pregnancy, the woman’s body undergoes anatomical and physiological changes, making this period susceptible to maternal-fetal diseases and complications. The consequences of not treating pregnant women include premature birth, low birth weight fetuses, and postnatal behavior disorders. Developing new therapies can accelerate the discovery of safe and effective drugs, contributing to designing novel natural and synthetic products to treat complications the pregnancy.

Objective

This study aimed to carry out a patent review to identify and explore trends in innovation and therapeutic strategies for treating pregnant women.

Methods

The Espacenet and WIPO databases were used, with the inclusion criteria being the keywords “pregnancy and drug” and code A61k, from 2008 to 2023, and as exclusion were the access to the patent and focus on human pregnant women.

Results

After the final screening, 32 patents were selected, with strategies for the treatment of diseases in pregnant women. Of these, 20 patents are on preclinical studies on animals and 12 on pregnant women. It was observed that universities lead the ranking of applications (17/32), and China has the highest number of patents (18/32). Most findings contain herbal medicines and/or the association of natural extracts with synthetic drugs.

Conclusion

From this perspective, new drug administration systems were also developed, which can be a promising source for obtaining new medicines for the treatment of pregnant women; however, research is still limited and shows a gap in stimulating the rapid development of safe drugs that improve the health of pregnant women.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673296246240410093401
2024-04-24
2024-11-19

  • From This Site

    /content/journals/cmc/10.2174/0109298673296246240410093401
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. KazmaJ.M. van den AnkerJ. AllegaertK. DallmannA. AhmadziaH.K. Anatomical and physiological alterations of pregnancy.J. Pharmacokinet. Pharmacodyn.202047427128510.1007/s10928‑020‑09677‑132026239
     [Google Scholar]
  2. CabreraR.M. Linda LinY. LawE. KimJ. WlodarczykB.J. The teratogenic effects of sertraline in mice.Birth Defects Res.2020112131014102410.1002/bdr2.166032077266
     [Google Scholar]
  3. DabbC. DryerR. BruntonR.J. YapK. RoachV.J. Paternal pregnancy-related anxiety: Systematic review of men’s concerns and experiences during their partners’ pregnancies.J. Affect. Disord.202332364065810.1016/j.jad.2022.11.09236481231
     [Google Scholar]
  4. RacicotK. KwonJ.Y. AldoP. SilasiM. MorG. Understanding the complexity of the immune system during pregnancy.Am. J. Reprod. Immunol.201472210711610.1111/aji.1228924995526
     [Google Scholar]
  5. ShookL.L. KislalS. EdlowA.G. Fetal brain and placental programming in maternal obesity: A review of human and animal model studies.Prenat. Diagn.20204091126113710.1002/pd.572432362000
     [Google Scholar]
  6. Alegre-Del ReyE.J. Fénix-CaballeroS. Díaz-NavarroJ. Risk of medications in pregnancy: A problem of knowledge transfer with ethical repercussions.Cuad. Bioet.2019309919920731206299
     [Google Scholar]
  7. SunC. GroomK.M. OystonC. ChamleyL.W. ClarkA.R. JamesJ.L. The placenta in fetal growth restriction: What is going wrong?Placenta202096101810.1016/j.placenta.2020.05.00332421528
     [Google Scholar]
  8. MarxU. AkabaneT. AnderssonT.B. BakerE. BeilmannM. BekenS. Brendler-SchwaabS. CiritM. DavidR. DehneE.M. DurieuxI. EwartL. FitzpatrickS.C. FreyO. FuchsF. GriffithL.G. HamiltonG.A. HartungT. HoengJ. HogbergH. HughesD.J. IngberD.E. IskandarA. KanamoriT. KojimaH. KuehnlJ. LeistM. LiB. LoskillP. MendrickD.L. NeumannT. PalloccaG. RusynI. SmirnovaL. Steger-HartmannT. TagleD.A. TonevitskyA. TsybS. TrapecarM. Van de WaterB. Van den Eijnden-van RaaijJ. VultoP. WatanabeK. WolfA. ZhouX. RothA. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development.Altern. Anim. Exp.202037336539432113184
     [Google Scholar]
  9. MitchellA.A. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008.Am J Obstet Gynecol201151
     [Google Scholar]
  10. DavidA.L. AhmadziaH. AshcroftR. Bucci-RechtwegC. SpencerR.N. ThorntonS. Improving development of drug treatments for pregnant women and the fetus.Ther. Innov. Regul. Sci.202256697699010.1007/s43441‑022‑00433‑w35881237
     [Google Scholar]
  11. WaggonerM.R. LyerlyA.D. Clinical trials in pregnancy and the “shadows of thalidomide”: Revisiting the legacy of Frances Kelsey.Contemp. Clin. Trials202211910680610.1016/j.cct.2022.10680635654303
     [Google Scholar]
  12. Figueroa-EspadaC.G. HofbauerS. MitchellM.J. RileyR.S. Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancy.Adv. Drug Deliv. Rev.202016024426110.1016/j.addr.2020.09.00632956719
     [Google Scholar]
  13. GiacomeliR. Guerra TeixeiraF.E. CarvalhoF.B. PachecoC.O. Martins ParisottoA.J. Funguetto RibeiroA.C. Gomes de GomesM. HaasS.E. Curcumin-loaded poly(ϵ-caprolactone) lipid-core nanocapsules: Evaluation of fetal and maternal toxicity.Food Chem. Toxicol.202014411162510.1016/j.fct.2020.11162532738367
     [Google Scholar]
  14. Sueth-SantiagoV. Curcumin, the golden powder of turmeric: insights into chemistry and biological activities.Quim. Nova201538538552
     [Google Scholar]
  15. MendesM.L.S. MeloD.R.A. Technology assessment: A methodological proposal.Contemp. Adm. Mag.201721456958410.1590/1982‑7849rac2017170047
     [Google Scholar]
  16. PontaL. PuligaG. ManziniR. A measure of innovation performance: The Innovation Patent Index.Manage. Decis.20215913739810.1108/MD‑05‑2020‑0545
     [Google Scholar]
  17. RibeiroB. ShapiraP. Private and public values of innovation: A patent analysis of synthetic biology.Res. Policy202049110387510.1016/j.respol.2019.10387532015589
     [Google Scholar]
  18. HanY.J. Measuring industrial knowledge stocks with patents and papers.J. Informetrics20071426927610.1016/j.joi.2007.06.001
     [Google Scholar]
  19. CockburnI. LongG. The importance of patents to innovation: Updated cross-industry comparisons with biopharmaceuticals.Expert Opin. Ther. Pat.201525773974210.1517/13543776.2015.104076225927945
     [Google Scholar]
  20. PageM.J. McKenzieJ.E. BossuytP.M. BoutronI. HoffmannT.C. MulrowC.D. ShamseerL. TetzlaffJ.M. AklE.A. BrennanS.E. ChouR. GlanvilleJ. GrimshawJ.M. HróbjartssonA. LaluM.M. LiT. LoderE.W. Mayo-WilsonE. McDonaldS. McGuinnessL.A. StewartL.A. ThomasJ. TriccoA.C. WelchV.A. WhitingP. MoherD. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.BMJ2021372n7110.1136/bmj.n7133782057
     [Google Scholar]
  21. GeumY. KimM. How to identify promising chances for technological innovation: Keygraph-based patent analysis.Adv. Eng. Inform.20204610115510.1016/j.aei.2020.101155
     [Google Scholar]
  22. DantasS.L.C. OliveiraG.Y.M. CostaK.F.L. BarrosA.A. ChavesE.M.C. CarvalhoR.E.F.L. Experimental studies in the gestational period: overview of scientific production.Rev. Esc. Enferm. USP20185205210.1590/s1980‑220x2017024403325
     [Google Scholar]
  23. BannermanS. The world intellectual property organization and the sustainable development agenda.Futures202012210258610.1016/j.futures.2020.102586
     [Google Scholar]
  24. PalazzaniL. Clinical trials in the time of a pandemic: Implications for informed consent.BioLaw J.20212S3550
     [Google Scholar]
  25. JoshiM.D. Drug delivery during pregnancy: How can nanomedicine be used?Future Science2017
     [Google Scholar]
  26. Ambros-RudolphC.M. Disorders of pregnancy.Braun-Falco´s Dermatology.Springer20221501151210.1007/978‑3‑662‑63709‑8_81
     [Google Scholar]
  27. CairnsA.E. TuckerK.L. LeesonP. MackillopL. McManusR.J. Survey of healthcare professionals regarding adjustment of antihypertensive medication(s) in the postnatal period in women with hypertensive disorders of pregnancy.Pregnancy Hypertens.20166425625810.1016/j.preghy.2016.08.24027939462
     [Google Scholar]
  28. MalhaL. PodymowT. AugustP. Hypertension in pregnancy.Hypertension.Elsevier202450151710.1016/B978‑0‑323‑88369‑6.00044‑X
     [Google Scholar]
  29. ZhangB. LiangR. ZhengM. CaiL. FanX. Surface- functionalized nanoparticles as efficient tools in targeted therapy of pregnancy complications.Int. J. Mol. Sci.20192015364210.3390/ijms2015364231349643
     [Google Scholar]
  30. KamilevnaP.M.M. Method for preeclampsia prevention.World Intellectual Property Organization.Russian2019
     [Google Scholar]
  31. KucieneR. DulskieneV. Associations of maternal gestational hypertension with high blood pressure and overweight/obesity in their adolescent offspring: A retrospective cohort study.Sci. Rep.2022121380010.1038/s41598‑022‑07903‑z35260718
     [Google Scholar]
  32. PhippsE.A. ThadhaniR. BenzingT. KarumanchiS.A. Pre-eclampsia: Pathogenesis, novel diagnostics and therapies.Nat. Rev. Nephrol.201915527528910.1038/s41581‑019‑0119‑630792480
     [Google Scholar]
  33. YanjuanB.I. Obstetrical and gynecological drug for treating complications of pregnancy and preparation method thereof.Espacenet. LtdB.Y.T.C. China2018
     [Google Scholar]
  34. ZhouL. Astragalus membranaceus and Salvia miltiorrhiza ameliorate hypertensive renal damage through lncRNA-mRNA coexpression network.BioMed Res Int20222022300235310.1155/2022/3002353
     [Google Scholar]
  35. FangjunX.I.A. Drug for department of obstetrics and gynecology for treating pregnancy complication and manufacturing method thereof.C.N. Patent 104258292A2015
  36. DuT.T.H.U.T.D.U.X. Use of zanamivir in preparation of drug for treating or preventing preeclampsia.W.O. Patent 20221115432022
  37. LuY. ChenR. CaiJ. HuangZ. YuanH. The management of hypertension in women planning for pregnancy.Br. Med. Bull.20181281758410.1093/bmb/ldy03530371746
     [Google Scholar]
  38. HonigbergM.C. ZekavatS.M. AragamK. KlarinD. BhattD.L. ScottN.S. PelosoG.M. NatarajanP. Long-term cardiovascular risk in women with hypertension during pregnancy.J. Am. Coll. Cardiol.201974222743275410.1016/j.jacc.2019.09.05231727424
     [Google Scholar]
  39. Hyo-eunB.Y. Composition comprising htr3a agonist for preventing arrhythmia or cardiac death.K.R. Patent 1016947802017
  40. LiC. JiaW. YangJ. ChengC. OlaleyeO.E. Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines.Acta Pharmacol. Sin.202243123080309510.1038/s41401‑022‑00983‑736114271
     [Google Scholar]
  41. XiaoyunJ. CN106668023 Drug composition for treating pregnancy-induced hypertension.C.N. Patent 1066680232017
  42. LindJ.M. HennessyA. ChiuC.L. Association between a woman’s age at first birth and high blood pressure.Medicine20159416e69710.1097/MD.000000000000069725906097
     [Google Scholar]
  43. XiaoweiH.Y. GuoC.N. Obstetrics and gynecology drug for treating complication of pregnancy and preparation method thereof.C.N. Patent 109893586 2017
  44. WangH. RollsE.T. DuX. DuJ. YangD. LiJ. LiF. ChengW. FengJ. Severe nausea and vomiting in pregnancy: psychiatric and cognitive problems and brain structure in children.BMC Med.202018122810.1186/s12916‑020‑01701‑y32867775
     [Google Scholar]
  45. BustosM. VenkataramananR. CaritisS. Nausea and vomiting of pregnancy - What’s new?Auton. Neurosci.2017202627210.1016/j.autneu.2016.05.00227209471
     [Google Scholar]
  46. ResF.B.S. Drug composition for treating vomiting during pregnancy.C.N. Patent 103432126A2013
  47. AbramowitzA. MillerE.S. WisnerK.L. Treatment options for hyperemesis gravidarum.Arch. Women Ment. Health201720336337210.1007/s00737‑016‑0707‑428070660
     [Google Scholar]
  48. MandaogadeP.M. MaD. TalwarN. Disintegrant-free delayed release doxylamine and pyridoxine formulation and process of manufacturing.C.N. Patent 2858478A12014
     [Google Scholar]
  49. ZhenhuaH. Pharmaceutical composition for gestation reaction and method of preparing the same.C.N. Patent 1011386212008
  50. AllaisG. ChiarleG. SinigagliaS. ManaO. BenedettoC. Migraine during pregnancy and in the puerperium.Neurol. Sci.201940S1Suppl. 1819110.1007/s10072‑019‑03792‑930880362
     [Google Scholar]
  51. BurchR.C. BuseD.C. LiptonR.B. Migraine.Neurol. Clin.201937463164910.1016/j.ncl.2019.06.00131563224
     [Google Scholar]
  52. Jin GpJ.X.Z.H.Z.E.H. Medicine for treating migraine during pregnancy.C.N. Patent 1114816252020
  53. IslamA. FawadA. ShahA.A. JadoonH. SarwarI. AbbasiA.U. Analysis of two years cases of ectopic pregnancy.J. Ayub Med. Coll. Abbottabad2017291656728712177
     [Google Scholar]
  54. XinglanL. Medicine taken orally for the treatment of old ectopic pregnancy and method of preparation thereof.C.N. Patent 1048004342015
  55. VladimirovichZ.R.S. Method for preventing chronic hypoxia and foetal development retardation.R.U. Patent 00026995592019
  56. ZavadenkoN.N. SuvorinovaN.Iu. RumiantsevaM.V. OvchinnikovaA.A. The use of instenon in children with minimal brain dysfunction.Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova20021025293512087730
     [Google Scholar]
  57. SorouriK. LorenA.W. AmantF. PartridgeA.H. Patient-centered care in the management of cancer during pregnancy.Am. Soc. Clin. Oncol. Educ. Book20234343e10003710.1200/EDBK_10003737220323
     [Google Scholar]
  58. PiccinniG. ClarkC. CagnazzoE. Acute abdomen of non-obstetric origin in pregnancy. Practical Guide to Simulation in Delivery Room EmergenciesSpringer20239711210.1007/978‑3‑031‑10067‑3_5
     [Google Scholar]
  59. ZachariahS.K. FennM. JacobK. ArthungalS.A. ZachariahS.A. Management of acute abdomen in pregnancy: Current perspectives.Int. J. Womens Health20191111913410.2147/IJWH.S15150130804686
     [Google Scholar]
  60. LeiS.D. Drug for treating abdominal pain during pregnancy.C.N. Patent 1033860012013
  61. HualunD. Chinese herbal medicine for curing hypogastric pain in pregnancy for women.C.N. Patent 1019049652010
  62. BarbitoffY.A. TsarevA.A. VashukovaE.S. MaksiutenkoE.M. KovalenkoL.V. BelotserkovtsevaL.D. GlotovA.S. A data-driven review of the genetic factors of pregnancy complications.Int. J. Mol. Sci.2020219338410.3390/ijms2109338432403311
     [Google Scholar]
  63. ZhibinL.H. Novel application of Chinese herbal compound pharmaceutical composition.C.N. Patent 1043527112015
  64. HaoC. Nutrient preparation for promoting pregnancy and preventing miscarriage.C.N. Patent 1092880672019
  65. Sharifi-RadM. Anil KumarN.V. ZuccaP. VaroniE.M. DiniL. PanzariniE. RajkovicJ. Tsouh FokouP.V. AzziniE. PelusoI. Prakash MishraA. NigamM. El RayessY. BeyrouthyM.E. PolitoL. IritiM. MartinsN. MartorellM. DoceaA.O. SetzerW.N. CalinaD. ChoW.C. Sharifi-RadJ. Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases.Front. Physiol.20201169410.3389/fphys.2020.0069432714204
     [Google Scholar]
  66. KamilevnaP.M.M. Olina AnnaA. SadykovaG. Method of treatment of threatened preterm labor.World Intellectual Property Organization.R.U. Patent 00025784762016
     [Google Scholar]
  67. ChechkoN. LosseE. NehlsS. Pregnancy denial: Toward a new understanding of the underlying mechanisms.Curr. Psychiatry Rep.2023251049350010.1007/s11920‑023‑01448‑237597131
     [Google Scholar]
  68. WicklowB. RetnakaranR. Gestational diabetes mellitus and its implications across the life span.Diabetes Metab. J.202347333334410.4093/dmj.2022.034836750271
     [Google Scholar]
  69. ChoudhuryA.A. Devi RajeswariV. Gestational diabetes mellitus - A metabolic and reproductive disorder.Biomed. Pharmacother.202114311218310.1016/j.biopha.2021.11218334560536
     [Google Scholar]
  70. KimS.Y. EnglandL. WilsonH.G. BishC. SattenG.A. DietzP. Percentage of gestational diabetes mellitus attributable to overweight and obesity.Am. J. Public Health201010061047105210.2105/AJPH.2009.17289020395581
     [Google Scholar]
  71. WikensC.L.W.K.L. Use of lactic acid bacteria for treating or preventing gestational diabetes mellitus.R.U. Patent 00027693122022
  72. MhataN.T. NtlantsanaV. TomitaA.M. MwambeneK. SaloojeeS. Prevalence of depression, anxiety and burnout in medical students at the University of Namibia.S. Afr. J. Psychiatry2023291204410.4102/sajpsychiatry.v29i0.204437292521
     [Google Scholar]
  73. YuanL. LiY. YanH. XiaoC. LiuD. LiuX. GuanY. YuB. Effects of work-family conflict and anxiety in the relationship between work-related stress and job burnout in Chinese female nurses: A chained mediation modeling analysis.J. Affect. Disord.202332430931610.1016/j.jad.2022.12.11236586602
     [Google Scholar]
  74. KeshavarzM. AmzajerdiA. MontazeriA. BekhradiR. Effect of mint aroma on nausea, vomiting and anxiety in pregnant women.J. Family Med. Prim. Care2019882597260110.4103/jfmpc.jfmpc_480_1931548939
     [Google Scholar]
  75. FangW. Medicinal vinegar preventing and treating anxiety in pregnancy caused by yin deficiency.WIPOChina2018
     [Google Scholar]
  76. SiddiquiS.A. Ali RedhaA. SnoeckE.R. SinghS. Simal-GandaraJ. IbrahimS.A. JafariS.M. Anti-depressant properties of crocin molecules in saffron.Molecules2022277207610.3390/molecules2707207635408474
     [Google Scholar]
  77. BianzhuC. Vinegar preparation preventing and treating dizziness in pregnancy caused by qi and blood deficiency.C.N. Patent 1086354622018
  78. WangXiaoMeng Impact of Qi-invigorating traditional Chinese medicines on intestinal flora: A basis for rational choice of prebiotics.Chin J Nat Med.2017154241254
     [Google Scholar]
  79. BravoJ.A. ForsytheP. ChewM.V. EscaravageE. SavignacH.M. DinanT.G. BienenstockJ. CryanJ.F. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve.Proc. Natl. Acad. Sci. USA201110838160501605510.1073/pnas.110299910821876150
     [Google Scholar]
  80. SlickermanR. Use of lactic acid bacteria for treatment or prevention of at least one condition of postnatal depression and postnatal anxietyR.U. Patent 00027631722021
  81. LiangH. YanJ. Infection and Sepsis, in Explosive Blast Injuries: Principles and Practices.Springer202322725210.1007/978‑981‑19‑2856‑7_15
     [Google Scholar]
  82. Anatol’evichM.V.I. Drug preparation for toxicosis relief in early pregnancy exhibiting immune corrective, diuretic action.R.U. Patent 023810322010
  83. FÁTimaDe. Molecules that stimulate the immune system for treatment of drug addiction, methods of synthesis, antidrug vaccine and uses.W.O. Patent 20190211402019
  84. DahanO. Birthing as an experience of awe: Birthing consciousness and its long-term positive effects.J. Theor. Philos. Psychol.2023431163010.1037/teo0000214
     [Google Scholar]
  85. GauM.L. ChangC.Y. TianS.H. LinK.C. Effects of birth ball exercise on pain and self-efficacy during childbirth: A randomised controlled trial in Taiwan.Midwifery2011276e293e30010.1016/j.midw.2011.02.00421459499
     [Google Scholar]
  86. HaipengS.J. ZhangJ. GuoC.N. Traditional chinese medicine composition for promoting head delivery of mares at late pregnancy.C.N. Patent 1038005942014
  87. NewmanD.J. CraggG.M. Natural products as sources of new drugs from 1981 to 2014.J. Nat. Prod.201679362966110.1021/acs.jnatprod.5b0105526852623
     [Google Scholar]
  88. XuY.X.Z. XiS. QianX. Evaluating traditional chinese medicine and herbal products for the treatment of gestational diabetes mellitus.J. Diabetes Res.201910.1155/2019/9182595
     [Google Scholar]
  89. IllamolaS.M. AmaezeO.U. KrepkovaL.V. BirnbaumA.K. KaranamA. JobK.M. BortnikovaV.V. SherwinC.M.T. EnioutinaE.Y. Use of herbal medicine by pregnant women: What physicians need to know.Front. Pharmacol.202010148310.3389/fphar.2019.0148331998122
     [Google Scholar]
  90. BrownB. WrightC. Safety and efficacy of supplements in pregnancy.Nutr. Rev.2020781081382610.1093/nutrit/nuz10131925443
     [Google Scholar]
  91. ShandA.W. WallsM. ChatterjeeR. NassarN. KhambaliaA.Z. Dietary vitamin, mineral and herbal supplement use: A cross-sectional survey of before and during pregnancy use in Sydney, Australia.Aust. N. Z. J. Obstet. Gynaecol.201656215416110.1111/ajo.1241426490392
     [Google Scholar]
  92. ZhaoX. JiangY. ZhaoY. XiH. LiuC. QuF. FengX. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening.Eur. J. Clin. Microbiol. Infect. Dis.20203971209122010.1007/s10096‑020‑03897‑632328850
     [Google Scholar]
  93. de AraújoT.E. MiliánI.C.B. de SouzaG. da SilvaR.J. RosiniA.M. GuirelliP.M. FrancoP.S. BarbosaB.F. FerroE.A.V. da CostaI.N. Experimental models of maternal–fetal interface and their potential use for nanotechnology applications.Cell Biol. Int.2020441365010.1002/cbin.1122231469205
     [Google Scholar]
  94. JoshiG. PatelM. ChaudharyD. SawantK. Preparation and surface modification of polymeric nanoparticles for drug delivery: State of the art.Recent Pat. Drug Deliv. Formul.202114320121310.2174/187221131466620090410503632885767
     [Google Scholar]
  95. JianF.X. Placenta targeted delivery system and preparation method and application thereof.C.N. Patent 1095682682019
  96. XietongJ.Y. Preparation of placenta targeted nano-drug and application of placenta targeted nano-drug in treatment of pregnancy combined with autoimmune diseases.C.N. Patent 1150545872022
  97. CabralH. Pharmaceutical composition for administration to pregnant women or women who may be pregnant.W.O. Patent 20202093792020
  98. MasafumiM.E. TsujimotoJ.P. Drug for controlling labor pain and treating premature birth.J.P. Patent 20092698232009
  99. JohnM.S. Medical drug delivery systems.U.S. Patent 202002226282020
  100. PengJ. Device for applying medicine to vagina during pregnancy.C.N. Patent 2153095812021
  101. YuW.H. WangQ. KongC.N. Gelatin sponge drug-loaded particle and preparation method thereof.C.N. Patent 1106387622020
/content/journals/cmc/10.2174/0109298673296246240410093401
Loading
A Systematic Patent Review (2008-2023) for Treatment in Pregnancy
Curr. Med. Chem. 31, 6288 (2024); https://doi.org/10.2174/0109298673296246240410093401
/content/journals/cmc/10.2174/0109298673296246240410093401
/content/journals/cmc/10.2174/0109298673296246240410093401
Loading

Data & Media loading...

Supplements

PRISMA checklist and supplementary material are available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Review Article
Keyword(s): diseases; drug; innovation; medicinal; natural products; Pregnancy

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test